Nutritional Growth Solutions Full Year 2024 Earnings: US$0.04 loss per share (vs US$0.15 loss in FY 2023)

Simply Wall St.
03-01

Nutritional Growth Solutions (ASX:NGS) Full Year 2024 Results

Key Financial Results

  • Revenue: US$2.48m (down 17% from FY 2023).
  • Net loss: US$2.54m (loss narrowed by 12% from FY 2023).
  • US$0.04 loss per share (improved from US$0.15 loss in FY 2023).
ASX:NGS Earnings and Revenue History February 28th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Nutritional Growth Solutions shares are down 20% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Nutritional Growth Solutions has 6 warning signs (and 4 which are concerning) we think you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10